NextCure, Inc. — Director's Dealing 2019

Jun 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-06-13

Reporting Person: KABAKOFF DAVID S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-13	Stock Option (Right to Buy)	$15.57	A	22000	Acquired	2029-06-12	Common Stock (22000)	Direct

Footnotes

F1: The option vests in three equal annual installments beginning on June 13, 2020.